NO820979L - Fremgangsmaate for fremstilling av pyridinderivater - Google Patents

Fremgangsmaate for fremstilling av pyridinderivater

Info

Publication number
NO820979L
NO820979L NO820979A NO820979A NO820979L NO 820979 L NO820979 L NO 820979L NO 820979 A NO820979 A NO 820979A NO 820979 A NO820979 A NO 820979A NO 820979 L NO820979 L NO 820979L
Authority
NO
Norway
Prior art keywords
procedure
pyridine derivatives
preparing pyridine
preparing
derivatives
Prior art date
Application number
NO820979A
Other languages
English (en)
Other versions
NO159850C (no
NO159850B (no
Inventor
Philippe Manoury
Jean Binet
Icilio Cavero
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO820979L publication Critical patent/NO820979L/no
Publication of NO159850B publication Critical patent/NO159850B/no
Publication of NO159850C publication Critical patent/NO159850C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO820979A 1981-03-25 1982-03-24 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinderivater. NO159850C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8106005A FR2502618A1 (fr) 1981-03-25 1981-03-25 Derives de pyridine, leur preparation et leur application en therapeutique

Publications (3)

Publication Number Publication Date
NO820979L true NO820979L (no) 1982-09-27
NO159850B NO159850B (no) 1988-11-07
NO159850C NO159850C (no) 1989-02-15

Family

ID=9256643

Family Applications (1)

Application Number Title Priority Date Filing Date
NO820979A NO159850C (no) 1981-03-25 1982-03-24 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinderivater.

Country Status (20)

Country Link
US (1) US4406907A (no)
EP (1) EP0061379B1 (no)
JP (1) JPS57169462A (no)
AR (1) AR231281A1 (no)
AT (1) ATE15895T1 (no)
AU (1) AU545747B2 (no)
CA (1) CA1185978A (no)
DE (1) DE3266607D1 (no)
DK (1) DK156652C (no)
ES (1) ES510724A0 (no)
FI (1) FI75808C (no)
FR (1) FR2502618A1 (no)
GR (1) GR75930B (no)
HU (1) HU186488B (no)
IE (1) IE52654B1 (no)
IL (1) IL65336A (no)
MX (1) MX156114A (no)
NO (1) NO159850C (no)
NZ (1) NZ200118A (no)
ZA (1) ZA822008B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2758820B1 (fr) * 1997-01-30 1999-02-26 Synthelabo Derives de alpha-azacyclomethyl-benzofurane, leur preparation et leur application en therapeutique
WO1998033793A1 (fr) * 1997-01-30 1998-08-06 Sanofi-Synthelabo DERIVES DE α-AZACYCLOMETHYL BENZOTHIOPHENE ET DE α-AZACYCLOMETHYL BENZOFURANE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
KR20220042293A (ko) 2019-08-05 2022-04-05 베이징 즈지엔진루이 셩우이야오 커지 요우시엔공스 질소 함유 다환 축합 고리계 화합물, 이의 약학 조성물, 제조 방법 및 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115575A (en) * 1973-02-20 1978-09-19 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)-pyrazines
US4195090A (en) * 1973-02-20 1980-03-25 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)pyridine derivatives and pharmaceutical compositions therewith
AR208397A1 (es) * 1973-02-20 1976-12-27 Ciba Geigy Ag Procedimiento para la elaboracion de compuestos de 1-piridiloxi-2-hidroxi-3-amino-propano1-piraziniloxi-2-hidroxi-3-amino-propano y 1-pirimidiniloxi-2-hidroxi-3-amino-propan

Also Published As

Publication number Publication date
MX156114A (es) 1988-07-12
IE820682L (en) 1982-09-25
FR2502618B1 (no) 1983-12-23
EP0061379A1 (fr) 1982-09-29
FI821034L (fi) 1982-09-26
NZ200118A (en) 1984-09-28
DK156652C (da) 1990-02-05
AU8187382A (en) 1982-09-30
FI75808C (fi) 1988-08-08
EP0061379B1 (fr) 1985-10-02
DK156652B (da) 1989-09-18
DK133282A (da) 1982-09-26
IL65336A (en) 1985-08-30
HU186488B (en) 1985-08-28
NO159850C (no) 1989-02-15
FI821034A0 (fi) 1982-03-24
JPS57169462A (en) 1982-10-19
JPS6135185B2 (no) 1986-08-12
AU545747B2 (en) 1985-08-01
GR75930B (no) 1984-08-02
ES8303346A1 (es) 1983-02-01
AR231281A1 (es) 1984-10-31
IE52654B1 (en) 1988-01-06
IL65336A0 (en) 1982-05-31
NO159850B (no) 1988-11-07
ATE15895T1 (de) 1985-10-15
ES510724A0 (es) 1983-02-01
FR2502618A1 (fr) 1982-10-01
CA1185978A (en) 1985-04-23
FI75808B (fi) 1988-04-29
DE3266607D1 (en) 1985-11-07
ZA822008B (en) 1983-02-23
US4406907A (en) 1983-09-27

Similar Documents

Publication Publication Date Title
NO850300L (no) Fremgangsmaate for fremstilling av 3-imidazolylmetyl-tetrahydrokarbazolon-derivater
NO822216L (no) Fremgangsmaate for fremstilling av bromhexin-retardform
NO851921L (no) Fremgangsmaate for fremstilling av pyrido-imidazo-rifanycin-derivater.
NO820253L (no) Fremgangsmaate for fremstilling av furo-(3,4-c)pyridin-derivater
NO810610L (no) Fremgangsmaate for fremstilling av piperidinderivater
NO813208L (no) Fremgangsmaate for fremstilling av 3-aryl-5-isotiazol-derivater.
NO851466L (no) Fremgangsmaate for fremstilling av 9a-aza-9a-homoery-tromycin-derivater.
NO822510L (no) Fremgangsmaate til fremstilling av pyridazinderivater
NO813442L (no) Fremgangsmaate for fremstilling av 2-guanidin-4-heteroaryltiazolderivater
FI822464A0 (fi) Benzotiazolsulfonamidderivat foer lokal behandling av oekat intraokulaert tryck
NO823637L (no) Fremgangsmaate for fremstilling av eburnamoninderivater
NO820980L (no) Fremgangsmaate for fremstilling av imidazo-pyrimidin-derivater
DK505482A (da) Fremgangsmaade til fremstilling af pyridinderivater
NO791604L (no) Fremangsmaate for fremstilling av di-o-n-alkyl-glycerolderivater
NO812841L (no) Fremgangsmaate til fremstilling av florerte pentendiaminderivater
DK123183D0 (da) Fremgangsmade til fremstilling af pyridinderivater
NO845038L (no) Fremgangsmaate for fremstilling av 4,5,6,7-tetrahydrotiazolo(5,4-c)pyridin-derivater
NO165107C (no) Fremgangsmaate for fremstilling av pyrido-imidazo-rifamycin-derivater.
NO841965L (no) Fremgangsmaate for fremstilling av 1,8-dihydroksy-10-acyl-9-antron-derivater
NO851550L (no) Fremgangsmaate for fremstilling av imidazolderivater
NO845016L (no) Fremgangsmaate ved fremstilling av substituerte spiropyridinderivater
NO803051L (no) Fremgangsmaate for fremstilling av pyridinderivater
NO820979L (no) Fremgangsmaate for fremstilling av pyridinderivater
RO82034A (ro) Procedeu pentru prepararea 3-picolinei
ES526647A0 (es) Metodo de preparar derivados de p-acilaminofenol